1-161362384-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 4P and 3B. PM1PM2BP4_ModerateBP6

The NM_003001.5(SDHC):​c.461T>C​(p.Val154Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V154L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

SDHC
NM_003001.5 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -1.31

Publications

1 publications found
Variant links:
Genes affected
SDHC (HGNC:10682): (succinate dehydrogenase complex subunit C) This gene encodes one of four nuclear-encoded subunits that comprise succinate dehydrogenase, also known as mitochondrial complex II, a key enzyme complex of the tricarboxylic acid cycle and aerobic respiratory chains of mitochondria. The encoded protein is one of two integral membrane proteins that anchor other subunits of the complex, which form the catalytic core, to the inner mitochondrial membrane. There are several related pseudogenes for this gene on different chromosomes. Mutations in this gene have been associated with paragangliomas. Alternatively spliced transcript variants have been described. [provided by RefSeq, May 2013]
SDHC Gene-Disease associations (from GenCC):
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • pheochromocytoma/paraganglioma syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Carney-Stratakis syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • gastrointestinal stromal tumor
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial disease
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM1
In a chain Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (size 139) in uniprot entity C560_HUMAN there are 20 pathogenic changes around while only 6 benign (77%) in NM_003001.5
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07640582).
BP6
Variant 1-161362384-T-C is Benign according to our data. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369. Variant chr1-161362384-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 534369.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SDHCNM_003001.5 linkc.461T>C p.Val154Ala missense_variant Exon 6 of 6 ENST00000367975.7 NP_002992.1 Q99643-1A0A0S2Z4B7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SDHCENST00000367975.7 linkc.461T>C p.Val154Ala missense_variant Exon 6 of 6 1 NM_003001.5 ENSP00000356953.3 Q99643-1

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151636
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461626
Hom.:
0
Cov.:
35
AF XY:
0.00000138
AC XY:
1
AN XY:
727116
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33472
American (AMR)
AF:
0.00
AC:
0
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111824
Other (OTH)
AF:
0.00
AC:
0
AN:
60376
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151636
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74042
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41218
American (AMR)
AF:
0.00
AC:
0
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10548
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67944
Other (OTH)
AF:
0.00
AC:
0
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Gastrointestinal stromal tumor;C1854336:Pheochromocytoma/paraganglioma syndrome 3 Uncertain:1
Mar 28, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 154 of the SDHC protein (p.Val154Ala). This variant is present in population databases (no rsID available, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with SDHC-related conditions. ClinVar contains an entry for this variant (Variation ID: 534369). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Hereditary cancer-predisposing syndrome Benign:1
Jan 12, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.043
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
0.58
DANN
Benign
0.68
DEOGEN2
Benign
0.16
T;.;.
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0054
N
LIST_S2
Benign
0.45
T;T;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.076
T;T;T
MetaSVM
Benign
-0.76
T
PhyloP100
-1.3
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.3
N;N;N
REVEL
Uncertain
0.37
Sift
Benign
0.52
T;T;T
Sift4G
Benign
0.61
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.029
MutPred
0.53
Loss of sheet (P = 0.0054);.;.;
MVP
0.61
MPC
2.2
ClinPred
0.024
T
GERP RS
-11
Varity_R
0.025
gMVP
0.36
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1378160712; hg19: chr1-161332174; API